nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—CHRM3—epilepsy syndrome	0.271	0.371	CbGaD
Propantheline—CHRM1—epilepsy syndrome	0.253	0.346	CbGaD
Propantheline—CHRM2—epilepsy syndrome	0.207	0.283	CbGaD
Propantheline—Methantheline—CHRM1—epilepsy syndrome	0.00239	0.548	CrCbGaD
Propantheline—Isopropamide—CHRM3—epilepsy syndrome	0.00102	0.234	CrCbGaD
Propantheline—Isopropamide—CHRM1—epilepsy syndrome	0.000952	0.218	CrCbGaD
Propantheline—Headache—Lacosamide—epilepsy syndrome	0.000244	0.00137	CcSEcCtD
Propantheline—Constipation—Vigabatrin—epilepsy syndrome	0.000243	0.00136	CcSEcCtD
Propantheline—Urticaria—Midazolam—epilepsy syndrome	0.000243	0.00136	CcSEcCtD
Propantheline—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000242	0.00136	CcSEcCtD
Propantheline—Drowsiness—Gabapentin—epilepsy syndrome	0.000242	0.00136	CcSEcCtD
Propantheline—Asthenia—Acetazolamide—epilepsy syndrome	0.000242	0.00135	CcSEcCtD
Propantheline—Somnolence—Felbamate—epilepsy syndrome	0.000241	0.00135	CcSEcCtD
Propantheline—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.00024	0.00135	CcSEcCtD
Propantheline—Vomiting—Clobazam—epilepsy syndrome	0.00024	0.00135	CcSEcCtD
Propantheline—Insomnia—Zonisamide—epilepsy syndrome	0.00024	0.00134	CcSEcCtD
Propantheline—Constipation—Diazepam—epilepsy syndrome	0.000239	0.00134	CcSEcCtD
Propantheline—Dry mouth—Lamotrigine—epilepsy syndrome	0.000239	0.00134	CcSEcCtD
Propantheline—Rash—Clobazam—epilepsy syndrome	0.000238	0.00134	CcSEcCtD
Propantheline—Dermatitis—Clobazam—epilepsy syndrome	0.000238	0.00133	CcSEcCtD
Propantheline—Headache—Clobazam—epilepsy syndrome	0.000237	0.00133	CcSEcCtD
Propantheline—Tachycardia—Carbamazepine—epilepsy syndrome	0.000236	0.00133	CcSEcCtD
Propantheline—Confusional state—Lamotrigine—epilepsy syndrome	0.000236	0.00132	CcSEcCtD
Propantheline—Somnolence—Zonisamide—epilepsy syndrome	0.000236	0.00132	CcSEcCtD
Propantheline—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000234	0.00131	CcSEcCtD
Propantheline—Urticaria—Fosphenytoin—epilepsy syndrome	0.000232	0.0013	CcSEcCtD
Propantheline—Constipation—Felbamate—epilepsy syndrome	0.000232	0.0013	CcSEcCtD
Propantheline—Nausea—Lacosamide—epilepsy syndrome	0.000231	0.0013	CcSEcCtD
Propantheline—Insomnia—Clonazepam—epilepsy syndrome	0.000231	0.0013	CcSEcCtD
Propantheline—Feeling abnormal—Diazepam—epilepsy syndrome	0.000231	0.00129	CcSEcCtD
Propantheline—Abdominal distension—Topiramate—epilepsy syndrome	0.00023	0.00129	CcSEcCtD
Propantheline—Insomnia—Phenytoin—epilepsy syndrome	0.00023	0.00129	CcSEcCtD
Propantheline—Tachycardia—Lamotrigine—epilepsy syndrome	0.000229	0.00128	CcSEcCtD
Propantheline—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000228	0.00128	CcSEcCtD
Propantheline—Dysphagia—Topiramate—epilepsy syndrome	0.000228	0.00128	CcSEcCtD
Propantheline—Somnolence—Clonazepam—epilepsy syndrome	0.000227	0.00127	CcSEcCtD
Propantheline—Constipation—Zonisamide—epilepsy syndrome	0.000227	0.00127	CcSEcCtD
Propantheline—Urticaria—Vigabatrin—epilepsy syndrome	0.000226	0.00127	CcSEcCtD
Propantheline—Somnolence—Phenytoin—epilepsy syndrome	0.000226	0.00127	CcSEcCtD
Propantheline—Hypersensitivity—Midazolam—epilepsy syndrome	0.000225	0.00126	CcSEcCtD
Propantheline—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000224	0.00126	CcSEcCtD
Propantheline—Nausea—Clobazam—epilepsy syndrome	0.000224	0.00126	CcSEcCtD
Propantheline—Asthenia—Propofol—epilepsy syndrome	0.000224	0.00126	CcSEcCtD
Propantheline—Tension—Valproic Acid—epilepsy syndrome	0.000224	0.00125	CcSEcCtD
Propantheline—Feeling abnormal—Felbamate—epilepsy syndrome	0.000223	0.00125	CcSEcCtD
Propantheline—Dizziness—Acetazolamide—epilepsy syndrome	0.000223	0.00125	CcSEcCtD
Propantheline—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000223	0.00125	CcSEcCtD
Propantheline—Urticaria—Diazepam—epilepsy syndrome	0.000222	0.00125	CcSEcCtD
Propantheline—Nervousness—Valproic Acid—epilepsy syndrome	0.000221	0.00124	CcSEcCtD
Propantheline—Flushing—Pregabalin—epilepsy syndrome	0.00022	0.00123	CcSEcCtD
Propantheline—Asthenia—Midazolam—epilepsy syndrome	0.00022	0.00123	CcSEcCtD
Propantheline—Insomnia—Carbamazepine—epilepsy syndrome	0.000219	0.00123	CcSEcCtD
Propantheline—Constipation—Clonazepam—epilepsy syndrome	0.000219	0.00123	CcSEcCtD
Propantheline—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000218	0.00123	CcSEcCtD
Propantheline—Constipation—Phenytoin—epilepsy syndrome	0.000217	0.00122	CcSEcCtD
Propantheline—Asthenia—Levetiracetam—epilepsy syndrome	0.000217	0.00122	CcSEcCtD
Propantheline—Constipation—Oxcarbazepine—epilepsy syndrome	0.000216	0.00121	CcSEcCtD
Propantheline—Somnolence—Carbamazepine—epilepsy syndrome	0.000215	0.00121	CcSEcCtD
Propantheline—Urticaria—Felbamate—epilepsy syndrome	0.000215	0.00121	CcSEcCtD
Propantheline—Vision blurred—Valproic Acid—epilepsy syndrome	0.000215	0.0012	CcSEcCtD
Propantheline—Vomiting—Acetazolamide—epilepsy syndrome	0.000214	0.0012	CcSEcCtD
Propantheline—Insomnia—Lamotrigine—epilepsy syndrome	0.000212	0.00119	CcSEcCtD
Propantheline—Headache—Acetazolamide—epilepsy syndrome	0.000211	0.00118	CcSEcCtD
Propantheline—Urticaria—Zonisamide—epilepsy syndrome	0.000211	0.00118	CcSEcCtD
Propantheline—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000211	0.00118	CcSEcCtD
Propantheline—Erectile dysfunction—Topiramate—epilepsy syndrome	0.00021	0.00118	CcSEcCtD
Propantheline—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000209	0.00117	CcSEcCtD
Propantheline—Asthenia—Fosphenytoin—epilepsy syndrome	0.000209	0.00117	CcSEcCtD
Propantheline—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000209	0.00117	CcSEcCtD
Propantheline—Somnolence—Lamotrigine—epilepsy syndrome	0.000208	0.00117	CcSEcCtD
Propantheline—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000208	0.00117	CcSEcCtD
Propantheline—Constipation—Carbamazepine—epilepsy syndrome	0.000207	0.00116	CcSEcCtD
Propantheline—Dizziness—Propofol—epilepsy syndrome	0.000207	0.00116	CcSEcCtD
Propantheline—Hypersensitivity—Diazepam—epilepsy syndrome	0.000206	0.00116	CcSEcCtD
Propantheline—Asthenia—Vigabatrin—epilepsy syndrome	0.000204	0.00114	CcSEcCtD
Propantheline—Urticaria—Clonazepam—epilepsy syndrome	0.000203	0.00114	CcSEcCtD
Propantheline—Dizziness—Midazolam—epilepsy syndrome	0.000202	0.00113	CcSEcCtD
Propantheline—Tension—Pregabalin—epilepsy syndrome	0.000202	0.00113	CcSEcCtD
Propantheline—Urticaria—Phenytoin—epilepsy syndrome	0.000202	0.00113	CcSEcCtD
Propantheline—Palpitations—Valproic Acid—epilepsy syndrome	0.000201	0.00113	CcSEcCtD
Propantheline—Asthenia—Diazepam—epilepsy syndrome	0.000201	0.00113	CcSEcCtD
Propantheline—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000201	0.00112	CcSEcCtD
Propantheline—Constipation—Lamotrigine—epilepsy syndrome	0.0002	0.00112	CcSEcCtD
Propantheline—Nervousness—Pregabalin—epilepsy syndrome	0.0002	0.00112	CcSEcCtD
Propantheline—Nausea—Acetazolamide—epilepsy syndrome	0.0002	0.00112	CcSEcCtD
Propantheline—Dizziness—Levetiracetam—epilepsy syndrome	0.0002	0.00112	CcSEcCtD
Propantheline—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.0002	0.00112	CcSEcCtD
Propantheline—Vomiting—Propofol—epilepsy syndrome	0.000199	0.00112	CcSEcCtD
Propantheline—Rash—Propofol—epilepsy syndrome	0.000197	0.00111	CcSEcCtD
Propantheline—Dermatitis—Propofol—epilepsy syndrome	0.000197	0.0011	CcSEcCtD
Propantheline—Headache—Propofol—epilepsy syndrome	0.000196	0.0011	CcSEcCtD
Propantheline—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000195	0.0011	CcSEcCtD
Propantheline—Vomiting—Midazolam—epilepsy syndrome	0.000195	0.00109	CcSEcCtD
Propantheline—Asthenia—Felbamate—epilepsy syndrome	0.000194	0.00109	CcSEcCtD
Propantheline—Vision blurred—Pregabalin—epilepsy syndrome	0.000194	0.00109	CcSEcCtD
Propantheline—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000193	0.00108	CcSEcCtD
Propantheline—Rash—Midazolam—epilepsy syndrome	0.000193	0.00108	CcSEcCtD
Propantheline—Dizziness—Fosphenytoin—epilepsy syndrome	0.000193	0.00108	CcSEcCtD
Propantheline—Dermatitis—Midazolam—epilepsy syndrome	0.000193	0.00108	CcSEcCtD
Propantheline—Urticaria—Carbamazepine—epilepsy syndrome	0.000192	0.00108	CcSEcCtD
Propantheline—Vomiting—Levetiracetam—epilepsy syndrome	0.000192	0.00108	CcSEcCtD
Propantheline—Headache—Midazolam—epilepsy syndrome	0.000192	0.00107	CcSEcCtD
Propantheline—Rash—Levetiracetam—epilepsy syndrome	0.000191	0.00107	CcSEcCtD
Propantheline—Dermatitis—Levetiracetam—epilepsy syndrome	0.00019	0.00107	CcSEcCtD
Propantheline—Asthenia—Zonisamide—epilepsy syndrome	0.00019	0.00107	CcSEcCtD
Propantheline—Dry mouth—Valproic Acid—epilepsy syndrome	0.00019	0.00106	CcSEcCtD
Propantheline—Headache—Levetiracetam—epilepsy syndrome	0.000189	0.00106	CcSEcCtD
Propantheline—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000188	0.00106	CcSEcCtD
Propantheline—Dizziness—Vigabatrin—epilepsy syndrome	0.000188	0.00105	CcSEcCtD
Propantheline—Confusional state—Valproic Acid—epilepsy syndrome	0.000188	0.00105	CcSEcCtD
Propantheline—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000187	0.00105	CcSEcCtD
Propantheline—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000186	0.00104	CcSEcCtD
Propantheline—Urticaria—Lamotrigine—epilepsy syndrome	0.000186	0.00104	CcSEcCtD
Propantheline—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000186	0.00104	CcSEcCtD
Propantheline—Nausea—Propofol—epilepsy syndrome	0.000186	0.00104	CcSEcCtD
Propantheline—Tension—Gabapentin—epilepsy syndrome	0.000185	0.00104	CcSEcCtD
Propantheline—Vomiting—Fosphenytoin—epilepsy syndrome	0.000185	0.00104	CcSEcCtD
Propantheline—Dizziness—Diazepam—epilepsy syndrome	0.000185	0.00104	CcSEcCtD
Propantheline—Rash—Fosphenytoin—epilepsy syndrome	0.000184	0.00103	CcSEcCtD
Propantheline—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000184	0.00103	CcSEcCtD
Propantheline—Nervousness—Gabapentin—epilepsy syndrome	0.000184	0.00103	CcSEcCtD
Propantheline—Asthenia—Clonazepam—epilepsy syndrome	0.000183	0.00103	CcSEcCtD
Propantheline—Headache—Fosphenytoin—epilepsy syndrome	0.000183	0.00102	CcSEcCtD
Propantheline—Palpitations—Pregabalin—epilepsy syndrome	0.000182	0.00102	CcSEcCtD
Propantheline—Asthenia—Phenytoin—epilepsy syndrome	0.000182	0.00102	CcSEcCtD
Propantheline—Nausea—Midazolam—epilepsy syndrome	0.000182	0.00102	CcSEcCtD
Propantheline—Tachycardia—Valproic Acid—epilepsy syndrome	0.000182	0.00102	CcSEcCtD
Propantheline—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000181	0.00102	CcSEcCtD
Propantheline—Vomiting—Vigabatrin—epilepsy syndrome	0.000181	0.00101	CcSEcCtD
Propantheline—Nausea—Levetiracetam—epilepsy syndrome	0.000179	0.00101	CcSEcCtD
Propantheline—Rash—Vigabatrin—epilepsy syndrome	0.000179	0.00101	CcSEcCtD
Propantheline—Dizziness—Felbamate—epilepsy syndrome	0.000179	0.001	CcSEcCtD
Propantheline—Dermatitis—Vigabatrin—epilepsy syndrome	0.000179	0.001	CcSEcCtD
Propantheline—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000179	0.001	CcSEcCtD
Propantheline—Vision blurred—Gabapentin—epilepsy syndrome	0.000178	0.000999	CcSEcCtD
Propantheline—Headache—Vigabatrin—epilepsy syndrome	0.000178	0.000999	CcSEcCtD
Propantheline—Vomiting—Diazepam—epilepsy syndrome	0.000178	0.000998	CcSEcCtD
Propantheline—Rash—Diazepam—epilepsy syndrome	0.000176	0.000989	CcSEcCtD
Propantheline—Dermatitis—Diazepam—epilepsy syndrome	0.000176	0.000989	CcSEcCtD
Propantheline—Dizziness—Zonisamide—epilepsy syndrome	0.000175	0.000983	CcSEcCtD
Propantheline—Headache—Diazepam—epilepsy syndrome	0.000175	0.000983	CcSEcCtD
Propantheline—Asthenia—Carbamazepine—epilepsy syndrome	0.000174	0.000975	CcSEcCtD
Propantheline—Nausea—Fosphenytoin—epilepsy syndrome	0.000173	0.000971	CcSEcCtD
Propantheline—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000173	0.000967	CcSEcCtD
Propantheline—Vomiting—Felbamate—epilepsy syndrome	0.000172	0.000966	CcSEcCtD
Propantheline—Dry mouth—Pregabalin—epilepsy syndrome	0.000172	0.000962	CcSEcCtD
Propantheline—Rash—Felbamate—epilepsy syndrome	0.000171	0.000958	CcSEcCtD
Propantheline—Dermatitis—Felbamate—epilepsy syndrome	0.000171	0.000957	CcSEcCtD
Propantheline—Headache—Felbamate—epilepsy syndrome	0.00017	0.000952	CcSEcCtD
Propantheline—Confusional state—Pregabalin—epilepsy syndrome	0.00017	0.000951	CcSEcCtD
Propantheline—Flushing—Topiramate—epilepsy syndrome	0.00017	0.000951	CcSEcCtD
Propantheline—Dizziness—Clonazepam—epilepsy syndrome	0.000169	0.000948	CcSEcCtD
Propantheline—Nausea—Vigabatrin—epilepsy syndrome	0.000169	0.000947	CcSEcCtD
Propantheline—Vomiting—Zonisamide—epilepsy syndrome	0.000169	0.000945	CcSEcCtD
Propantheline—Insomnia—Valproic Acid—epilepsy syndrome	0.000168	0.000944	CcSEcCtD
Propantheline—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000168	0.000943	CcSEcCtD
Propantheline—Asthenia—Lamotrigine—epilepsy syndrome	0.000168	0.000942	CcSEcCtD
Propantheline—Dizziness—Phenytoin—epilepsy syndrome	0.000168	0.000941	CcSEcCtD
Propantheline—Rash—Zonisamide—epilepsy syndrome	0.000167	0.000937	CcSEcCtD
Propantheline—Palpitations—Gabapentin—epilepsy syndrome	0.000167	0.000937	CcSEcCtD
Propantheline—Dermatitis—Zonisamide—epilepsy syndrome	0.000167	0.000937	CcSEcCtD
Propantheline—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000167	0.000936	CcSEcCtD
Propantheline—Nausea—Diazepam—epilepsy syndrome	0.000166	0.000932	CcSEcCtD
Propantheline—Headache—Zonisamide—epilepsy syndrome	0.000166	0.000931	CcSEcCtD
Propantheline—Somnolence—Valproic Acid—epilepsy syndrome	0.000165	0.000928	CcSEcCtD
Propantheline—Tachycardia—Pregabalin—epilepsy syndrome	0.000164	0.000921	CcSEcCtD
Propantheline—Vomiting—Clonazepam—epilepsy syndrome	0.000162	0.000911	CcSEcCtD
Propantheline—Vomiting—Phenytoin—epilepsy syndrome	0.000161	0.000905	CcSEcCtD
Propantheline—Rash—Clonazepam—epilepsy syndrome	0.000161	0.000903	CcSEcCtD
Propantheline—Dermatitis—Clonazepam—epilepsy syndrome	0.000161	0.000903	CcSEcCtD
Propantheline—Nausea—Felbamate—epilepsy syndrome	0.000161	0.000902	CcSEcCtD
Propantheline—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000161	0.0009	CcSEcCtD
Propantheline—Dizziness—Carbamazepine—epilepsy syndrome	0.00016	0.000898	CcSEcCtD
Propantheline—Headache—Clonazepam—epilepsy syndrome	0.00016	0.000898	CcSEcCtD
Propantheline—Rash—Phenytoin—epilepsy syndrome	0.00016	0.000897	CcSEcCtD
Propantheline—Dermatitis—Phenytoin—epilepsy syndrome	0.00016	0.000897	CcSEcCtD
Propantheline—Rash—Oxcarbazepine—epilepsy syndrome	0.000159	0.000893	CcSEcCtD
Propantheline—Constipation—Valproic Acid—epilepsy syndrome	0.000159	0.000892	CcSEcCtD
Propantheline—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000159	0.000892	CcSEcCtD
Propantheline—Headache—Phenytoin—epilepsy syndrome	0.000159	0.000892	CcSEcCtD
Propantheline—Headache—Oxcarbazepine—epilepsy syndrome	0.000158	0.000887	CcSEcCtD
Propantheline—Nausea—Zonisamide—epilepsy syndrome	0.000157	0.000883	CcSEcCtD
Propantheline—Dry mouth—Gabapentin—epilepsy syndrome	0.000157	0.000882	CcSEcCtD
Propantheline—Tension—Topiramate—epilepsy syndrome	0.000156	0.000875	CcSEcCtD
Propantheline—Confusional state—Gabapentin—epilepsy syndrome	0.000156	0.000872	CcSEcCtD
Propantheline—Dizziness—Lamotrigine—epilepsy syndrome	0.000155	0.000868	CcSEcCtD
Propantheline—Nervousness—Topiramate—epilepsy syndrome	0.000154	0.000866	CcSEcCtD
Propantheline—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000154	0.000865	CcSEcCtD
Propantheline—Vomiting—Carbamazepine—epilepsy syndrome	0.000154	0.000864	CcSEcCtD
Propantheline—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000153	0.00086	CcSEcCtD
Propantheline—Rash—Carbamazepine—epilepsy syndrome	0.000153	0.000857	CcSEcCtD
Propantheline—Dermatitis—Carbamazepine—epilepsy syndrome	0.000153	0.000856	CcSEcCtD
Propantheline—Insomnia—Pregabalin—epilepsy syndrome	0.000152	0.000853	CcSEcCtD
Propantheline—Nausea—Clonazepam—epilepsy syndrome	0.000152	0.000851	CcSEcCtD
Propantheline—Headache—Carbamazepine—epilepsy syndrome	0.000152	0.000851	CcSEcCtD
Propantheline—Nausea—Phenytoin—epilepsy syndrome	0.000151	0.000845	CcSEcCtD
Propantheline—Tachycardia—Gabapentin—epilepsy syndrome	0.000151	0.000844	CcSEcCtD
Propantheline—Nausea—Oxcarbazepine—epilepsy syndrome	0.00015	0.000841	CcSEcCtD
Propantheline—Vision blurred—Topiramate—epilepsy syndrome	0.00015	0.00084	CcSEcCtD
Propantheline—Somnolence—Pregabalin—epilepsy syndrome	0.00015	0.000839	CcSEcCtD
Propantheline—Vomiting—Lamotrigine—epilepsy syndrome	0.000149	0.000835	CcSEcCtD
Propantheline—Urticaria—Valproic Acid—epilepsy syndrome	0.000148	0.000829	CcSEcCtD
Propantheline—Rash—Lamotrigine—epilepsy syndrome	0.000148	0.000828	CcSEcCtD
Propantheline—Dermatitis—Lamotrigine—epilepsy syndrome	0.000148	0.000827	CcSEcCtD
Propantheline—Headache—Lamotrigine—epilepsy syndrome	0.000147	0.000823	CcSEcCtD
Propantheline—Nausea—Carbamazepine—epilepsy syndrome	0.000144	0.000807	CcSEcCtD
Propantheline—Constipation—Pregabalin—epilepsy syndrome	0.000144	0.000807	CcSEcCtD
Propantheline—Palpitations—Topiramate—epilepsy syndrome	0.000141	0.000788	CcSEcCtD
Propantheline—Insomnia—Gabapentin—epilepsy syndrome	0.00014	0.000782	CcSEcCtD
Propantheline—Nausea—Lamotrigine—epilepsy syndrome	0.000139	0.00078	CcSEcCtD
Propantheline—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000139	0.000777	CcSEcCtD
Propantheline—Somnolence—Gabapentin—epilepsy syndrome	0.000137	0.000769	CcSEcCtD
Propantheline—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000137	0.000769	CcSEcCtD
Propantheline—Urticaria—Pregabalin—epilepsy syndrome	0.000134	0.000749	CcSEcCtD
Propantheline—Asthenia—Valproic Acid—epilepsy syndrome	0.000134	0.000749	CcSEcCtD
Propantheline—Dry mouth—Topiramate—epilepsy syndrome	0.000132	0.000742	CcSEcCtD
Propantheline—Constipation—Gabapentin—epilepsy syndrome	0.000132	0.00074	CcSEcCtD
Propantheline—Confusional state—Topiramate—epilepsy syndrome	0.000131	0.000734	CcSEcCtD
Propantheline—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000127	0.000713	CcSEcCtD
Propantheline—Tachycardia—Topiramate—epilepsy syndrome	0.000127	0.00071	CcSEcCtD
Propantheline—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000124	0.000695	CcSEcCtD
Propantheline—Dizziness—Valproic Acid—epilepsy syndrome	0.000123	0.00069	CcSEcCtD
Propantheline—Urticaria—Gabapentin—epilepsy syndrome	0.000123	0.000687	CcSEcCtD
Propantheline—Asthenia—Pregabalin—epilepsy syndrome	0.000121	0.000677	CcSEcCtD
Propantheline—Vomiting—Valproic Acid—epilepsy syndrome	0.000118	0.000663	CcSEcCtD
Propantheline—Insomnia—Topiramate—epilepsy syndrome	0.000117	0.000658	CcSEcCtD
Propantheline—Rash—Valproic Acid—epilepsy syndrome	0.000117	0.000658	CcSEcCtD
Propantheline—Dermatitis—Valproic Acid—epilepsy syndrome	0.000117	0.000657	CcSEcCtD
Propantheline—Headache—Valproic Acid—epilepsy syndrome	0.000117	0.000654	CcSEcCtD
Propantheline—Somnolence—Topiramate—epilepsy syndrome	0.000115	0.000647	CcSEcCtD
Propantheline—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000114	0.000637	CcSEcCtD
Propantheline—Dizziness—Pregabalin—epilepsy syndrome	0.000111	0.000624	CcSEcCtD
Propantheline—Constipation—Topiramate—epilepsy syndrome	0.000111	0.000622	CcSEcCtD
Propantheline—Asthenia—Gabapentin—epilepsy syndrome	0.000111	0.000621	CcSEcCtD
Propantheline—Nausea—Valproic Acid—epilepsy syndrome	0.000111	0.00062	CcSEcCtD
Propantheline—Vomiting—Pregabalin—epilepsy syndrome	0.000107	0.0006	CcSEcCtD
Propantheline—Feeling abnormal—Topiramate—epilepsy syndrome	0.000107	0.0006	CcSEcCtD
Propantheline—Rash—Pregabalin—epilepsy syndrome	0.000106	0.000595	CcSEcCtD
Propantheline—Dermatitis—Pregabalin—epilepsy syndrome	0.000106	0.000594	CcSEcCtD
Propantheline—Headache—Pregabalin—epilepsy syndrome	0.000105	0.000591	CcSEcCtD
Propantheline—Urticaria—Topiramate—epilepsy syndrome	0.000103	0.000578	CcSEcCtD
Propantheline—Dizziness—Gabapentin—epilepsy syndrome	0.000102	0.000572	CcSEcCtD
Propantheline—Nausea—Pregabalin—epilepsy syndrome	9.99e-05	0.00056	CcSEcCtD
Propantheline—Vomiting—Gabapentin—epilepsy syndrome	9.81e-05	0.00055	CcSEcCtD
Propantheline—Rash—Gabapentin—epilepsy syndrome	9.73e-05	0.000545	CcSEcCtD
Propantheline—Dermatitis—Gabapentin—epilepsy syndrome	9.72e-05	0.000545	CcSEcCtD
Propantheline—Headache—Gabapentin—epilepsy syndrome	9.66e-05	0.000542	CcSEcCtD
Propantheline—Hypersensitivity—Topiramate—epilepsy syndrome	9.56e-05	0.000536	CcSEcCtD
Propantheline—Asthenia—Topiramate—epilepsy syndrome	9.31e-05	0.000522	CcSEcCtD
Propantheline—Nausea—Gabapentin—epilepsy syndrome	9.16e-05	0.000514	CcSEcCtD
Propantheline—Dizziness—Topiramate—epilepsy syndrome	8.58e-05	0.000481	CcSEcCtD
Propantheline—Vomiting—Topiramate—epilepsy syndrome	8.25e-05	0.000463	CcSEcCtD
Propantheline—Rash—Topiramate—epilepsy syndrome	8.18e-05	0.000459	CcSEcCtD
Propantheline—Dermatitis—Topiramate—epilepsy syndrome	8.18e-05	0.000458	CcSEcCtD
Propantheline—Headache—Topiramate—epilepsy syndrome	8.13e-05	0.000456	CcSEcCtD
Propantheline—Nausea—Topiramate—epilepsy syndrome	7.71e-05	0.000432	CcSEcCtD
Propantheline—CHRM3—Metabolism—ABCG2—epilepsy syndrome	1.66e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.65e-05	0.000192	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.64e-05	0.00019	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.63e-05	0.00019	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.62e-05	0.000188	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.62e-05	0.000188	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	1.61e-05	0.000187	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.61e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.61e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.61e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	1.6e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.6e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.6e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.59e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.59e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.57e-05	0.000182	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	1.56e-05	0.000182	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.56e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	1.56e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.55e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.54e-05	0.000179	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.52e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	1.51e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.5e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.5e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.49e-05	0.000173	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.48e-05	0.000172	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.47e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.47e-05	0.000171	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.46e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.45e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.42e-05	0.000165	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.4e-05	0.000163	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.39e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.39e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.39e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.39e-05	0.000161	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.38e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.38e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.37e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.37e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.36e-05	0.000158	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.36e-05	0.000158	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.35e-05	0.000157	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.35e-05	0.000157	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.34e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.34e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.32e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.32e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.31e-05	0.000152	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.3e-05	0.000151	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—TH—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1.29e-05	0.00015	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	1.28e-05	0.000148	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.26e-05	0.000147	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	1.26e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.25e-05	0.000145	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.22e-05	0.000142	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.22e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.22e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.22e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	1.21e-05	0.000141	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.2e-05	0.00014	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	1.2e-05	0.00014	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	1.2e-05	0.00014	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.2e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	1.2e-05	0.000139	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SST—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SST—epilepsy syndrome	1.18e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.17e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	1.17e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	1.17e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	1.17e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SST—epilepsy syndrome	1.17e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.16e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	1.16e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	1.16e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.15e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	1.15e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.14e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	1.14e-05	0.000132	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	1.11e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.1e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	1.1e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.09e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	1.09e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	1.09e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.09e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	1.09e-05	0.000126	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—HMOX1—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	1.08e-05	0.000125	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.07e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAT—epilepsy syndrome	1.07e-05	0.000124	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	1.06e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	1.05e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ABCB1—epilepsy syndrome	1.04e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.04e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	1.03e-05	0.00012	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	1.02e-05	0.000119	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.02e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	1.01e-05	0.000118	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	1.01e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	1e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	9.97e-06	0.000116	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	9.92e-06	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	9.89e-06	0.000115	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	9.88e-06	0.000115	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	9.85e-06	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	9.8e-06	0.000114	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	9.75e-06	0.000113	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GPX1—epilepsy syndrome	9.63e-06	0.000112	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	9.39e-06	0.000109	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	9.36e-06	0.000109	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	9.29e-06	0.000108	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	9.27e-06	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	9.26e-06	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	9.26e-06	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	9.24e-06	0.000107	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	9.17e-06	0.000107	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	9.15e-06	0.000106	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	8.98e-06	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	8.95e-06	0.000104	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	8.86e-06	0.000103	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	8.49e-06	9.85e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	8.46e-06	9.82e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AGT—epilepsy syndrome	8.45e-06	9.81e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	8.38e-06	9.73e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOE—epilepsy syndrome	8.28e-06	9.61e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	8.25e-06	9.58e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	8.23e-06	9.55e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	8.22e-06	9.55e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	8.21e-06	9.53e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	8.2e-06	9.52e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	8.18e-06	9.5e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	8.15e-06	9.46e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	8.12e-06	9.42e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	8.1e-06	9.41e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.93e-06	9.21e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	7.91e-06	9.18e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	7.85e-06	9.11e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	7.83e-06	9.09e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	7.82e-06	9.08e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	7.74e-06	8.99e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	7.63e-06	8.86e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	7.61e-06	8.83e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	7.53e-06	8.75e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	7.47e-06	8.67e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	7.44e-06	8.64e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	7.37e-06	8.56e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—POMC—epilepsy syndrome	7.11e-06	8.25e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	7.09e-06	8.24e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	7.09e-06	8.23e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	7.07e-06	8.21e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	7.06e-06	8.2e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	7e-06	8.13e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	7e-06	8.12e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	6.94e-06	8.06e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	6.92e-06	8.03e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	6.85e-06	7.96e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	6.8e-06	7.9e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	6.78e-06	7.87e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	6.71e-06	7.8e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	6.55e-06	7.6e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	6.53e-06	7.58e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	6.52e-06	7.57e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	6.5e-06	7.55e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—epilepsy syndrome	6.48e-06	7.53e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	6.46e-06	7.5e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	6.44e-06	7.47e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	5.96e-06	6.92e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	5.95e-06	6.9e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	5.89e-06	6.84e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	5.84e-06	6.78e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	5.82e-06	6.75e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	5.76e-06	6.69e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—epilepsy syndrome	5.67e-06	6.58e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	5.27e-06	6.12e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	5.26e-06	6.1e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	5.21e-06	6.04e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	4.9e-06	5.68e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	4.88e-06	5.67e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	4.83e-06	5.61e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	4.8e-06	5.57e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	4.79e-06	5.56e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	4.74e-06	5.5e-05	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.46e-06	5.17e-05	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	4.44e-06	5.16e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	4.42e-06	5.13e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	4.4e-06	5.11e-05	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	4.4e-06	5.11e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	4.36e-06	5.06e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	4.29e-06	4.98e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	4.28e-06	4.96e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	4.23e-06	4.92e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.17e-06	4.84e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	4.16e-06	4.83e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	4.12e-06	4.78e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.05e-06	4.7e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	4.03e-06	4.68e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	4e-06	4.64e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	3.85e-06	4.47e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	3.84e-06	4.45e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	3.8e-06	4.41e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.75e-06	4.35e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	3.74e-06	4.34e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.7e-06	4.29e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—epilepsy syndrome	2.85e-06	3.31e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.39e-06	2.78e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	2.38e-06	2.77e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.36e-06	2.74e-05	CbGpPWpGaD
